HEPATOCYTE GROWTH FACTOR (HGF) receptor is a member of the receptor tyrosine kinase superfamily and is encoded by the c-met protooncogene (3, 29) . Mature c-met receptor is a heterodimeric protein consisting of an extracellular ␣-subunit and a ␤-subunit harboring an extracellular portion, a transmembrane segment and the cytoplasmic tyrosine kinase domain (32) . On binding to its specific ligand, c-met receptor undergoes autophosphorylation of multiple tyrosine residues in its cytoplasmic region and triggers cascades of signal transduction events that lead to such diverse cellular responses as cell survival, proliferation, migration, and differentiation (5, 6, 17, (24) (25) (26) . Because all biological activities of HGF are mediated by a single receptor, the expression and levels of c-met protein not only determine the cell-type specificity of HGF actions but also dictate the overall activities of this paired signaling system. Consistent with this view, earlier studies indicate that it is the abundance and activity of c-met receptor, rather than HGF itself, that best correlate with the biological function of HGF in diverse organs under physiological and pathological conditions (8, 28, 39) .
The expression of the c-met receptor is primarily regulated at the transcriptional level (21) . Unlike its ligand, which is expressed mainly in mesenchymederived cells in normal tissues (19, 26) , c-met expression is relatively ubiquitous with a widespread pattern. For instance, in normal adult kidney and cultured kidney cells, c-met protein is detected in all types of renal cells including glomerular mesangial cells, podocytes, proximal tubular cells, collecting duct epithelial cells, and interstitial fibroblasts, although high level of c-met is only observed in distal tubules and collecting duct epithelia under normal circumstances (46) . This prevalent pattern of c-met constitutive expression is closely overlapped with, and predominantly dictated by, the ubiquitous specificity protein (Sp) family of transcription factors (18, 37, 46) . Both Sp1 and Sp3 avidly bind to the GC boxes (Sp1-binding sites) in the c-met promoter region and transcriptionally activate its expression; and together, they interact with each other, forming heterodimeric complexes and elicit synergistic actions on c-met gene transcription (46) . The broad expression pattern of the c-met gene likely highlights a wide implication of HGF in normal cell physiology in diverse organs.
A wide variety of cytokines, growth factors, and hormones has been reported to induce c-met expression in renal epithelial cells and other types of cells (21, 23, 27, 36) . Expression of the c-met gene is also induced rapidly in the injured organs after diverse types of tissue-injurious insults (20, 21) . Contrary to HGF whose expression is often stimulated in both injured and distal intact organs, c-met induction exclusively occurs at the site of injury and is principally correlated with the injury and subsequent repair process in a site-specific manner (14, 21, 34) . In addition, c-met expression is induced in renal epithelial cells by altered extracellular environmental cues such as a high concentration of glucose in vitro and in diabetic states in vivo (22) . Hence, in response to a vast diversity of stimuli, the c-met gene is commonly activated to induce its expression, a process that may be necessary and important for injury repair and regeneration. However, little is documented as to c-met transcriptional suppression in response to certain conditions, and it also remains largely unknown about the molecular mechanism governing c-met inhibition.
In this report, we demonstrate that oxidative stress inhibits c-met gene expression at both mRNA and protein levels. The suppression of c-met expression is accompanied by induction of Egr-1 transcription factor in renal epithelial cells after H 2 O 2 treatment. Our results suggest that Egr-1 sequesters Sp1 by physical interaction, which leads to a decreased availability of free Sp1 for c-met transcriptional activation.
MATERIALS AND METHODS
Cell culture and treatment. Mouse inner medullary collecting duct epithelial cell line 3 (mIMCD-3) was obtained from American Type Culture Collection (ATCC, Manassas, VA). Human kidney proximal tubular cells (HKC) were provided by Dr. L. Racusen of Johns Hopkins University (Baltimore, MD). Cells were maintained in DMEM and Ham's F-12 medium (1:1 of DMEM/F12; Life Technologies, Grand Island, NY) supplemented with 10% FBS. Cells were seeded in plastic petri dishes (100 mm; Falcon) at 60-70% confluence. After being cultivated for 16 h in the complete medium containing 10% FBS, cells were serum-starved for 24 h and incubated for various periods of time as indicated in the absence (control) or presence of 0.5 mM H 2O2 (Sigma-Aldrich, St. Louis, MO), except when otherwise indicated. The cells were then collected for analysis of gene expression at both mRNA and protein levels by Northern and Western blot analyses, respectively.
RNA preparation and Northern blot analysis. Total RNA was extracted from the cells using Ultraspec RNA solution (Biotecx, Houston, TX) according to the instructions specified by the manufacturer. Samples of 20 g total RNA were electrophoresed on 1.0% formadehyde-agarose gels and then transferred to GeneScreen plus nylon membrane (DuPont, Boston, MA) by capillary blotting followed by ultraviolet cross-linking. Membranes were prehybridized for 4 h at 65°C in a buffer containing 6ϫ SSC, 5ϫ Denhardt's solution, 1% SDS, 10% dextran sulfate, and 100 g/ml denatured salmon sperm DNA.
32 P-labeled DNA probes were prepared by the random primer labeling kit (Stratagene, La Jolla, CA) using [␣-
32 P]dCTP. The rat c-met cDNA probe was generated in our laboratory as described previously (23) . The human egr-1 cDNA was obtained from the ATCC. Denatured probes were added to the same hybridization buffer at a concentration of 1-2 ϫ 10 6 cpm/ml, and hybridization was allowed to proceed at 65°C for 16 h. Membranes were washed and exposed to X-ray film (Eastman Kodak, Rochester, NY) at Ϫ80°C with the aid of an intensifying screen as described elsewhere (21, 44) . Quantitation was performed by determination of the intensity of the hybridization signals using the National Institutes of Health Image program.
Western blot analysis. The mIMCD-3 cells were solubilized with RIPA lysis buffer (1% Nonidet P-40, 0.1% SDS, 100 g/ml phenylmethylsulfonyl fluoride, 0.5% sodium deoxycholate, 1 mM sodium orthovanadate, 2 g/ml aprotin, 2 g/ml leupeptin in PBS) at 4°C for 20 min, and the supernatants were collected after centrifugation at 13,000 g at 4°C for 10 min. Protein concentration was determined using a bicinchoninic acid (BCA) protein assay kit with bovine serum albumin as a standard (Sigma), and cell lysates were mixed with an equal amount of 2ϫ loading buffer (100 mM Tris ⅐ HCl, 4% SDS, 20% glycerol, and 0.2% bromophenol blue). Samples were heated at 100°C for 10 min before loading and separated on precasted 10% SDS-polyacrylamide gels (Bio-Rad, Hercules, CA) under nonreducing conditions. The proteins were transferred to a nitrocellulose membrane (Amersham, Arlington Heights, IL) in transfer buffer containing 48 mM Tris ⅐ HCl, 39 mM glycine, 0.037% SDS, and 20% methanol at 4°C for 2 h. Nonspecific binding to the membrane was blocked for 1 h at room temperature with 5% nonfat milk in TBS buffer (20 mM Tris ⅐ HCl, 150 mM NaCl, and 0.1% Tween 20) , and then the membrane was incubated for 1 h with various primary antibodies followed by incubation for 1 h with a secondary horseradish peroxidase-conjugated IgG in 5% nonfat milk. The specific antibodies against c-met, Egr-1, Sp1, Sp3, and actin, were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The signals were visualized by the enhanced chemiluminescence system (ECL, Amersham) as described elsewhere (43) .
Construction of plasmid, DNA transfection, and luciferase assay. The various chimeric plasmids containing different lengths of the 5Ј-flanking region of the human c-met gene linked to the coding sequence for chloramphenicol acetyltransferase (CAT) had been described previously (18) . In this study, the highly sensitive firefly luciferase reporter system was used. For that purpose, various DNA fragments containing different lengths of the c-met promoter region were excised with SstI and BglII from different c-met-CAT reporter plasmid vectors. The DNA fragments were gel purified and then subcloned into the SstI/BglII site of the promoterless pGL3-Basic luciferase expression vector (Promega, Madison, WI). The resultant chimeric reporter plasmids (designated as pGL3-0.7met, pGL3-0.2met, or pGL3-0.1met, etc.) were verified by detailed restriction mapping. For transient transfection, the mIMCD-3 cells were seeded in six-well plates at 2 ϫ 10 5 cells/well. The cells were then transfected with various luciferase reporter plasmids using the Lipofectamine 2000 reagent according to the instructions specified by the manufacturer (Life Technologies). A fixed amount of internal control reporter Renilla reniformis luciferase driven under thymidine kinase (TK) promoter (pRL-TK, Promega) was cotransfected for normalizing the transfection efficiency and correcting firefly luciferase activity. After transfection, the cells were incubated for an additional 24 h in the absence or presence of 0.5 mM H2O2 before being harvested for luciferase assay. Luciferase assay was performed using the Dual Luciferase Assay System kit essentially according to the protocol specified by the manufacturer (Promega). Relative luciferase activity of each construct (arbitrary unit) was reported as fold-induction over pGL3-0.1met after normalizing for transfection efficiency. All experiments were repeated in a minimum of three separate experiments (triple wells per experiment) to assume reproducibility. The values from these experiments were combined and subjected to analysis of variance using SigmaStat statistical software (Jandel Scientific, San Rafael, CA). P Ͻ 0.05 was considered significant.
Preparation of nuclear protein extract. The control and H 2O2-treated mIMCD-3 cells were cultured in the conditions described above. For preparation of nuclear protein extracts, cells were washed twice with cold PBS and scraped off the plate with a rubber policeman. Cells were collected and the nuclei were isolated according to the method described elsewhere (9, 46) . Briefly, the pelleted cells were resuspended in 4 vol of buffer A containing protease inhibitors (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2, 0.5% Nonidet P-40, 10 mM KCl, 0.2 mM PMSF, and 0.5 mM dithiothreitol plus 1% protease inhibitor cocktail from Sigma-Aldrich). The cell suspension was transferred into a Dounce homogenizer immediately after incubation on ice for 10 min to allow the cells to swell. The cells were then lysed by 10 strokes. Cell nuclei were collected by centrifugation at 3,500 g for 15 min at 4°C and suspended in the same volume of buffer A without Nonidet P-40. The nuclei were resuspended in 150 l of buffer B (20 mM HEPES, pH 7.9, 10% glycerol, 1.5 mM MgCl 2, 10 mM KCl, 0.2 mM EDTA, 0.2 mM PMSF, and 0.5 mM dithiothreitol plus protease inhibitor cocktail). Fiftymicroliters of buffer B containing 1.6 M KCl were added into the nuclei suspension in a dropwise fashion, followed by incubation on ice for 1 h. The nuclear extracts were collected by centrifugation at 4°C at 25,000 g for 30 min. Aliquots of protein extract were quickly frozen and stored at Ϫ80°C after the protein concentration had been determined using a BCA protein assay kit (Sigma-Aldrich).
EMSA. The double-strand Sp1/Egr-1 oligonucleotide (oligo) corresponding to the nucleotide sequence of Ϫ86ϳϪ61 in the c-met promoter which contains a perfect Sp1 site overlapped with an imperfect Egr-1 site was labeled with [␥-32 P]ATP using T4 kinase (Life Technologies). An oligo containing two Egr-1-binding sites was purchased from Santa Cruz Biotechnology and used as a positive control for Egr-1 binding. The labeled probes were then gel purified and used in EMSA as described previously (46) . Four micrograms of Poly(dI-dC)-Poly(dI-dC) (Pharmacia, Piscataway, NJ) were used as the nonspecific competitor in 10 l reaction mixture. The binding reactions were carried out at 37°C for 30 min before loading of 5% nondenaturing polyacrylamide (19:1, acrylamide:bisacrylamide) gels. For competition experiments, 100-fold molar excess of unlabeled double-strand oligo was included in the reaction mixture except where indicated otherwise. For supershift experiments, specific antibodies against Sp1, Sp3, Egr-1, and normal control IgG (Santa Cruz) were incubated with nuclear protein extracts for 30 min at 37°C before addition of reaction buffer. Gels were run in 0.5ϫ TBE buffer (0.045 M Tris ⅐ borate, 0.001 M EDTA) at a constant voltage of 190 V, dried, and autoradiographed with intensifying screens.
Immunoprecipitation. Renal epithelial mIMCD-3 cells grown on 100-mm plate were lysed on ice in 1 ml RIPA buffer containing 1ϫ PBS, 1% Nonidet P-40, 0.1% SDS, 10 g/ml phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, and 1% protease inhibitors cocktail (Sigma). Whole cell lysates were clarified by centrifugation at 12,000 g for 10 min at 4°C, and the supernatants were transferred into a fresh tube. To preclear cell lysates, 0.25 g of normal rabbit IgG and 20 l of protein A/G Plus-Agarose (Santa Cruz) were added into 1 ml of whole cell lysates. After incubation for 1 h at 4°C, supernatants were collected by centrifugation at 1,000 g for 5 min at 4°C. Lysates were immunoprecipitated overnight at 4°C with 1 g of anti-Sp1 and anti-Egr-1, respectively, followed by precipitation with 20 l of protein A/G Plus-Agarose for 3 h at 4°C. After four washes with RIPA buffer, the immunoprecipitates were boiled for 5 min in SDS sample buffer. The resulting precipitated complexes were separated on SDS-polyacrylamide gels and blotted with various antibodies as described above.
RESULTS
Oxidative stress inhibits c-met expression while concomitantly inducing egr-1. We investigated the effects of oxidative stress on c-met gene expression in renal epithelial cells in vitro. As shown in Fig. 1 , incubation of renal collecting duct epithelial cells (mIMCD-3) with 0.5 mM H 2 O 2 markedly suppressed the steady-state levels of c-met mRNA in a time-dependent manner. At 6 h after H 2 O 2 treatment, ϳ70% inhibition of c-met mRNA was observed in mIMCD-3 cells, as determined by quantitatively measuring the intensity of the hybridization signal. This inhibition of c-met expression by H 2 O 2 was also dose dependent, and significant inhibition of c-met mRNA was observed at a concentration as low as 0.05 mM (data not shown). Of note, at the concentration of 0.5 mM as used in this study, H 2 O 2 did not significantly cause cell death, as the lactase dehydrogenase activity in the supernatant of control and H 2 O 2 -treated mIMCD-3 cell culture is essentially identical (data not shown). H 2 O 2 also had no appreciable effects on housekeeping gene GAPDH expression.
Of interest, we found that the inhibition of c-met expression by oxidative stress was accompanied by a marked induction of an early growth responsive gene (egr-1). Northern blot analysis indicated that 0.5 mM H 2 O 2 induced a rapid increase in the steady-state level of egr-1 mRNA, which peaked at 3 h after oxidative stress (Fig. 1) . A close correlation between c-met suppression and egr-1 induction was observed in renal epithelial cells at different time points after H 2 O 2 treatment (Fig. 1 ). Of note, the peak of egr-1 induction preceded the maximal inhibition of c-met gene expression in response to oxidative stress (Fig. 1B) . In accordance with c-met suppression, induction of egr-1 expression mediated by oxidative stress was also dose dependent in renal epithelial cells (data not shown).
Similar to mRNA levels, c-met protein was also significantly reduced after incubation with 0.5 mM H 2 O 2 in renal epithelial cells (Fig. 2) . Western blot analysis revealed that H 2 O 2 suppressed c-met protein in a dosedependent fashion. As shown in Fig. 2 , inhibition of c-met protein expression coincided with induction of Egr-1 protein expression in renal epithelial cells in response to H 2 O 2 treatment. This reciprocal association between inhibition of c-met and induction of egr-1 by oxidative stress likely implies that these two events may be somehow interconnected in renal epithelial cells.
Ectopic expression of egr-1 suppresses endogenous c-met expression in renal epithelial cells. To test a direct relevance of Egr-1 induction and c-met suppression, we investigated the effects of ectopic expression of exogenous Egr-1 on c-met expression in renal tubular epithelial cells by transfecting the Egr-1 expression vector. As shown in Fig. 3, forced (Fig.  3C) . Similarly, expression of exogenous Egr-1 also inhibited endogenous c-met expression in HKC cells (Fig.  3, B and D) . Thus these results establish that Egr-1 may directly mediate the suppression of c-met expression by oxidative stress in renal tubular epithelial cells.
Promoter region responsible for c-met inhibition by oxidative stress contains both Egr-1-and Sp1-binding sites. To further investigate how Egr-1 mediates c-met inhibition by oxidative stress in renal epithelial cells, we defined the cis-acting element(s) responsible for c-met inhibition in the promoter region of the c-met gene. Various lengths of the c-met promoter region coupled with the firefly luciferase reporter gene were transfected into renal epithelial mIMCD-3 cells. The luciferase activities were determined in the transfected cells after incubation in the absence or presence of 0.5 mM H 2 O 2 for 24 h. As shown in Fig. 4 , H 2 O 2 significantly suppressed the reporter activities of pGL3-0.7met and pGL3-0.2met constructs that contain 0.7-and 0.2-kb 5Ј-flanking regions of the c-met gene, respectively. However, no significant inhibition of reporter activity was observed after transfection with pGL3-0.1met construct in response to H 2 O 2 treatment (1.0 Ϯ 0.03 in control vs. 0.58 Ϯ 0.06 in H 2 O 2 group, P ϭ 0.692, n ϭ 3). Hence, the cis-acting element responsible for c-met inhibition was largely localized at a 156-bp region corresponding to nucleotide position Ϫ223 to Ϫ68 of c-met gene. Sequence analysis revealed that there are an imperfect Egr-1-and three Sp1-binding sites within this region (Fig. 4C) (18) , which led us to speculate that alterations in cellular abundance or activity of Egr-1 and/or Sp proteins might be involved in mediating c-met inhibition in response to oxidative stress.
Egr-1 inhibits c-met promoter activity but does not directly bind to the cis-acting element. To establish the functional significance of Egr-1 in controlling c-met gene transcription, we examined the effects of overexpression of Egr-1 on c-met promoter activity by cotransfecting the Egr-1 expression vector and c-met promoter reporter construct into renal epithelial cells. As shown in Fig. 5 , transfection of increasing amounts of Egr-1 expression vector and pGL3-0.2met reporter construct that contains an imperfect Egr-1-binding site suppressed c-met promoter activity in a dose-dependent manner, suggesting that Egr-1 is critical for c-met transcriptional suppression.
We further investigated a potential interaction between Egr-1 protein and the cis-element in the c-met promoter. As the imperfect Egr-1-binding site partially overlaps with Sp1 site, one would speculate that increased Egr-1 in renal epithelial mIMCD-3 cells after H 2 O 2 treatment might compete with Sp1 for binding to that region. To further explore this possibility, we used oligo corresponding to this overlapping Sp1/Egr-1 site as a probe in EMSA. As shown in Fig. 6A , three major shifted bands were observed when the oligo was incubated with nuclear protein extract from H 2 O 2 -treated mIMCD-3 cells. Competition with unlabeled wild-type Sp1/Egr-1 oligo, but not mutant Sp1, largely abolished the binding. To determine the identity of these shifted bands, a supershift approach with specific antibodies was used. Shown in Fig. 6B , antibodies against Sp1 and Sp3, but not Egr-1, caused a further shift in polyacrylamide gels, indicating that Egr-1 does not bind to this imperfect Egr-1 site with a single mutation. Of note, double-strand oligo containing a perfect Egr-1-binding site did recognize Egr-1 protein in EMSA (Fig.  6C) . That Egr-1-binding activity was markedly induced in mIMCD-3 cells treated with H 2 O 2 (Fig. 6C) . Therefore, Egr-1 appears to inhibit c-met gene transcription by a mechanism independent of direct binding to its imperfect cis-element in c-met promoter.
Induction of Egr-1 by oxidative stress attenuates the binding of Sp1 to its cognate site but does not affect the cellular abundance of Sp proteins.
Given that Egr-1 does not bind to the c-met promoter, we next compared the binding ability of Sp1 protein to the Sp1/Egr-1 site under basal and H 2 O 2 -treated conditions. As shown in Fig. 7 , A and C, induction of Egr-1 by oxidative stress significantly suppressed the binding of Sp proteins to the c-met promoter. Weak Sp1 and Sp3 binding was observed when nuclear extract rich in Egr-1 from H 2 O 2 -treated mIMCD-3 cells was used, suggesting that a high level of Egr-1 may interfere with Sp protein binding. Of interest, preabsorption of the nuclear extract from H 2 O 2 -treated mIMCD-3 cells with antiEgr-1 antibody tended to restore the binding ability of Sp proteins (Fig. 7, B and D) . This implies that a high level of Egr-1 induced by oxidative stress is likely responsible for the attenuation of Sp proteins binding to c-met promoter in renal epithelial cells.
We next explored the possibility of whether a decreased Sp level accounts for c-met inhibition after oxidative stress, because earlier studies showed that both Sp1 and Sp3 play a crucial role in establishing c-met constitutive expression in the kidney (46) . As shown in Fig. 7E , no significant change was found in cellular levels of Sp1 protein in renal epithelial cells at different time points after 0.5 mM H 2 O 2 treatment, as revealed by Western blot analysis. H 2 O 2 also did not significantly affect the expression of Sp3 protein. Thus it is obvious that c-met suppression by oxidative stress is independent of the alteration in cellular levels of Sp proteins.
Physical interaction of Egr-1 with Sp1. The observation that Egr-1 does not directly bind to the c-met promoter (Fig. 6 ) raises an intriguing possibility that Egr-1 may affect the binding of Sp proteins to the c-met promoter through protein-protein interaction. To test this hypothesis, we examined the interaction between Egr-1 and Sp1 by a coimmunoprecipitation approach using specific antibodies against Egr-1 and Sp1. As shown in Fig. 8 , when cell lysates derived from either control or H 2 O 2 -treated renal epithelial mIMCD-3 cells were immunoprecipitated with anti-Sp1 antibody, Egr-1 was detected in the precipitated complexes (Fig.   Fig. 6 . Egr-1 does not bind to c-met gene promoter region. A and B: EMSA demonstrates that Egr-1 does not bind to the imperfect Egr-1-binding site of c-met promoter. Double-strand Sp1/Egr-1 oligonucleotide (oligo) corresponding to Ϫ86ϳϪ61 of the c-met promoter region that contains a perfect Sp1 site overlapped with an imperfect Egr-1 site (with a single mutation) was labeled with 32 P and incubated with the nuclear protein extract derived from mIMCD-3 cells treated with 0.5 mM H2O2. A: for competition experiments, a 100-fold excess of unlabeled probes was included in the binding mixtures. Oligo containing mutant Sp1-binding site was described previously (46) and also used as a competitor. B: for supershift experiments, nuclear protein extracts were incubated with antibodies against normal IgG, Sp1, Sp3, or Egr-1, respectively. C: Egr-1 in renal epithelial cells recognizes and binds to its cognate cis-acting element. Oligo containing 2 perfect Egr-1-binding sites was incubated with nuclear protein extracts derived from either control or H2O2-treated mIMCD-3 cells. Competition and supershift experiments were also carried out as indicated. Bottom: sequences of the probes. Arrows indicate binding complexes. Arrowheads denote supershifted complexes.
8A). The abundance of Egr-1 present in the precipitated complexes was largely proportional to the cellular Egr-1 level after H 2 O 2 treatment in a time-dependent manner. Similarly, Sp1 protein was also detected in the reciprocal experiments when cell lysates were immunoprecipitated with Egr-1 antibody (Fig. 8B) , suggesting that Egr-1 binds to Sp1 through a proteinprotein interaction. However, in control mIMCD-3 cells that are poor in Egr-1, Sp1 was not found in the Egr-1 immunoprecipates (Fig. 8B) . Therefore, it is conceivable that after oxidative stress, increased Egr-1 tends to bind Sp1 protein via protein-protein interaction, leading to sequestration of Sp1 for c-met gene transcriptional activation.
DISCUSSION
HGF receptor signaling plays a critical role in controlling diverse types of cellular responses such as cell survival, proliferation, migration, and differentiation (17, 25, 26, 42) . Given the importance of the c-met receptor in cell physiology, it is easy to realize that its expression is tightly controlled under normal physiological conditions. Aberrant regulation of the c-met expression has been implicated in developing various types of tumors in transgenic animal models and in patients (2, 4, 7, 12, 40) . Although many cytokines, growth factors, and hormones have been demonstrated to upregulate c-met expression in a wide variety of cells including renal epithelial cells (21, 27) , little is known as to the extracellular cues that suppress its expression (35) . In this report, we demonstrated that oxidative stress suppresses c-met expression in renal epithelial cells in a time-and dose-dependent fashion. This inhibition of c-met expression by oxidant stress is likely mediated by the interplay between Sp1 and Egr-1 transcription factors, in which induced Egr-1 sequesters Sp1's function as a transcriptional activator of the c-met gene through physical interaction.
One of the intriguing features in renal epithelial cells after oxidative stress is the concomitant and reciprocal expression of c-met and Egr-1 transcription factors ( Figs. 1 and 2 ). This inverse association between c-met and Egr-1 was later confirmed by ectopic expression of Egr-1 via transfection (Fig. 3) . Egr-1 is the prototypic member of the Egr family of transcription factors whose expression is rapidly induced in response to various stimuli (31, 47) . Egr-1 contains a DNA binding domain that is homologous to that found in Sp1 and recognizes and binds to the consensus GC-rich sequence 5Ј-GCGGGGGCG-3Ј of its target genes in a zinc-dependent manner (11, 15) . Although Egr-1 binding usually results in activation of gene transcription, it also suppresses gene transcription depending on specific context of the promoters (1, 33) . As to the c-met gene, we found that Egr-1 was unable to bind to the c-met promoter (Fig. 6 ) but markedly suppressed its transcription (Fig. 5) and protein expression (Fig. 3) , despite robust induction of Egr-1 transcript (Fig. 1), protein (Fig. 2) , and its DNA-binding activity (Fig. 6C ) in renal epithelial cells after H 2 O 2 treatment. The inability of Egr-1 to bind to the ciselement is likely attributable to the existence of an imperfect match (8 nucleotides of 9) in the putative Egr-1 site of the c-met promoter. This underscores that a single mutation in the core sequence of the Egr-1-binding site can cripple the interaction between the trans-acting factor and cis-acting element.
The involvement of Sp1 in mediating oxidative stress-triggered c-met suppression is initially hinted by the identification of a cis-acting H 2 O 2 -responsive region, which harbors three Sp1-binding sites and an imperfect Egr-1 site (Fig. 4) . Moreover, DNA-protein interaction studies reveal an attenuated binding of Sp proteins (Sp1 and Sp3) to their cognate sites when using nuclear extract from H 2 O 2 -treated renal epithelial cells (Fig. 7) . It should be noted that there is an additional perfect Sp1-binding site located at the nucleotide position of ϩ29 to ϩ34 relative to the c-met transcriptional initiation site (18) , which could explain the marginal reduction in luciferase activity in the pGL3-0.1met construct after H 2 O 2 treatment (Fig. 4) . These observations are consistent with earlier studies demonstrating that the Sp family of transcription factors is essential for establishing the constitutive expression of c-met gene in diverse types of cells (18, 36, 37, 46) . For instance, c-met expression in normal adult kidney is largely overlapped with Sp1 and Sp3, and the abundance of c-met is tightly proportional to endogenous cellular levels of Sp proteins (46) . Of importance, both Sp1 and Sp3 proteins trans-activate the c-met promoter in a highly synergistic way. However, treatment of renal epithelial cells with H 2 O 2 induced no alteration in cellular levels of both Sp1 and Sp3 (Fig.  7E) . Such observation establishes that oxidant stress suppresses c-met expression by a mechanism involving a possible interplay between Sp proteins and induced Egr-1 rather than any alteration in cellular level of Sp proteins.
Interplay between Egr-1 and Sp1 transcription factors has been described to mediate the transcriptional regulation of many genes (1, 10, 16, 30, 41) . Extensive studies indicate that the molecular mechanism governing the interaction between Egr-1 and Sp1 is overwhelmingly controlled through directly competing for binding to the overlapping cis-acting element. In many promoters containing GC-rich elements, Sp1-and Egr-1-binding sites often are partially overlapped by sharing several nucleotides in their respective core binding sequence. Thus overexpression or induction of one factor, leading to an increased cellular concentration, will result in "displacement" of another factor for binding to the overlapping sites. Such displacement of Sp1 by Egr-1, or vice versa, could lead to either transcriptional activation or repression, depending on a particular promoter and cellular content. For example, Egr-1 competes with Sp1 protein for an overlapping region in the promoter of platelet-derived growth factor A and functions as a positive activator (16) . Thus the Egr-1/ Sp1 displacement mechanism may be an important regulatory pathway in the control of inducible gene expression (16) . Contrary to this report, Egr-1 has been shown to act as a negative regulator and represses Sp1-mediated activation of many genes including protein-tyrosine phosphatase 1B (10), Epstein-Barr virus C (30), and ␤ 1 -adrenergic receptor (1) . These studies suggest that Egr-1 and Sp1 often elicit opposite regulation of particular genes by competing for binding to an overlapping site and thereby displacing with each other. Hence, competition for DNA binding between inducible Egr-1 and constitutive Sp1 may provide a defined means of transcriptional regulation. Such a mechanism, however, could not account for the regulation of c-met expression in renal epithelial cells after oxidative stress, because Egr-1 does not directly bind to the c-met promoter (Fig. 6) .
The action of Egr-1 on gene transcription is also regulated through its phosphorylation by an inducible casein kinase II (13, 38, 45) . This represents an alternative mechanism implicating the interplay between Egr-1 and Sp1 in modulating gene transcription, besides the displacement of DNA binding. Previous studies show that estrogen blocks macrophage colony-stimulating factor (M-CSF) gene expression by decreasing casein kinase II-dependent phosphorylation of Egr-1 (38) . Phosphorylated Egr-1, possibly due to conformational changes of specific domains that modulate the affinity of Egr-1 for Sp1, binds less ardently to Sp1, which leads to higher levels of free Sp1 for stimulating activation of the M-CSF gene (38) . Therefore, posttranslational modification of Egr-1 also plays a critical role in regulating gene transcription by modulating the affinity of Egr-1 for Sp1. However, because it has not been tested whether oxidative stress affects the phosphorylation of Egr-1 in this study, it remains elusive whether this mode of regulation is related to c-met suppression by oxidative stress in renal epithelial cells.
Our findings in the present study unravel a distinctive mode of interaction between Egr-1 and Sp1 transcription factors, in which Egr-1 sequesters Sp1 for its transcriptional activation of the c-met gene. The sequestration of Sp1 by Egr-1 is most likely mediated through protein-protein interaction. This conclusion is consistent with, and supported by, several lines of observations. First, despite increased amounts of Egr-1 expression after oxidative stress in renal epithelial cells, Egr-1 did not directly bind to the c-met promoter. This excludes the possibility of a direct "displacement" of Sp1 by increasing Egr-1 after H 2 O 2 treatment via competition for binding. Second, physical interaction between Egr-1 and Sp1 is clearly evident, as illustrated by coimmunoprecipitation (Fig. 8) . It is unlikely that formation of the Egr-1/Sp1 complex requires the binding of both proteins to the cis-acting DNA element in the c-met promoter, because such a complex was absent in the EMSA studies (Fig. 6) . Third, ectopic expression of Egr-1 functionally suppresses c-met promoter and protein expression in renal epithelial cells, a scenario resembling that in renal epithelial cells where Egr-1 is abundant following oxidative stress. Because Egr-1 suppression of c-met expression does not require its binding to DNA element, our findings on Egr-1 sequestration of Sp1 may have broad implications in the regulation of any genes that are transcriptionally controlled by ubiquitous Sp1 and potentially provide a generalized mechanism elucidating how inducible Egr-1 protein controls the expression of a wide variety of genes, regardless of whether they have an Egr-1-binding site in their promoter regions.
In summary, we showed herein that oxidative stress suppresses c-met expression in renal epithelial cells in a time-and dose-dependent fashion. We demonstrate that Egr-1, the product of an inducible immediateearly responsive gene, is a key mediator of c-met inhibition, primarily by its sequestration of Sp1 as a transcriptional activator for the c-met gene via physical interaction. The results of this study provide the mechanistic insights into the transcriptional repression of the c-met gene and will form the basis for further analyses of the regulation of this important signaling molecule under normal and pathological settings.
